Egyptian Board Psychiatry common mistakes
Egyptian Board Psychiatry · Understand the traps and how to avoid them.
When asked to identify the most likely diagnosis in a clinical vignette, the candidate selects a diagnosis based on a single prominent symptom (e.g., hearing voices → schizophrenia) without verifying the duration, functional impact, and exclusion criteria required by ICD-10/DSM-5.
Candidates often rely on pattern recognition from a few keywords and skip systematic application of diagnostic criteria; under time pressure they anchor on the first diagnosis that comes to mind.
What to do instead
For every diagnostic question, explicitly list the required criteria (symptom count, duration, impairment, exclusions) and check each against the vignette. Practice with a mnemonic such as 'SIGECAPS' for depression or 'ABCDE' for schizophrenia, and always ask: what is the minimum duration? Is there functional decline? Could a substance or medical condition explain it?
In psychopharmacology questions, the candidate chooses a medication based on its class (e.g., 'SSRI for depression') without considering the patient's specific clinical features (e.g., comorbid OCD, bipolarity, pregnancy, renal impairment) or the receptor profile that determines side effects.
Candidates memorize drug classes but not the nuanced indications, contraindications, and side-effect profiles; they may also confuse atypical antipsychotics' receptor affinities (e.g., high H1 blockade → sedation) and miss the best match for the vignette.
What to do instead
Create a comparison table for each drug class listing key receptor targets, side effects, and special indications. For each question, underline the patient's unique features (e.g., 'breastfeeding', 'QT prolongation', 'non-adherence') and match them to the drug with the most favorable profile. Review high-yield distinctions such as clozapine for treatment-resistant schizophrenia and its monitoring requirements.
When asked about the mechanism of action or therapeutic approach in psychotherapy, the candidate gives a vague answer such as 'supportive therapy' or 'CBT' without specifying the core components, indications, or typical duration, and fails to distinguish between similar therapies (e.g., CBT vs. DBT vs. psychodynamic).
Psychotherapy content is often studied superficially; candidates memorize labels but not the active ingredients, and exam questions test the ability to match therapy to disorder and describe key techniques.
What to do instead
For each major therapy (CBT, DBT, psychodynamic, interpersonal, family, supportive), write a one-sentence definition, the disorders it is first-line for, and 2–3 signature techniques (e.g., DBT: mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness). Practice MCQs that ask 'which therapy is most appropriate' and justify your choice by linking the technique to the patient's problem.
In mood disorders, the candidate misclassifies a depressive episode as unipolar when there is a history of hypomania or mixed features, or fails to recognize bipolar depression and thus recommends an antidepressant alone, risking switch or rapid cycling.
Candidates often focus on the current depressive symptoms and forget to screen for lifetime manic/hypomanic episodes; they may also overlook mixed features in DSM-5 and the need for mood stabilizers.
What to do instead
Always screen for a history of elevated, expansive, or irritable mood with increased energy lasting at least 4 days (hypomania) or 1 week (mania). Use the Mood Disorder Questionnaire (MDQ) as a mental checklist. In treatment questions, if bipolar depression is suspected, prioritize quetiapine, lurasidone, or lithium plus antidepressant rather than antidepressant monotherapy.
In schizophrenia spectrum questions, the candidate confuses negative symptoms with depression or extrapyramidal side effects, and misattributes cognitive deficits to poor effort, leading to incorrect diagnosis or treatment choice.
Negative symptoms (flat affect, avolition, alogia) overlap with depression and parkinsonism; candidates may not know the distinguishing features (e.g., negative symptoms are persistent and not mood-congruent) and fail to consider the temporal relationship with antipsychotic initiation.
What to do instead
Learn the differential: negative symptoms are enduring, present since illness onset, and not accompanied by sadness or guilt; depression has prominent mood-congruent features; EPS emerges after antipsychotic initiation and improves with dose reduction or anticholinergics. Use the Positive and Negative Syndrome Scale (PANSS) framework to structure thinking. For treatment, remember that negative symptoms respond poorly to typical antipsychotics and may improve with clozapine or psychosocial interventions.
In anxiety and OCD/trauma-related disorders, the candidate recommends a benzodiazepine as first-line for OCD or PTSD, or fails to recognize that SSRIs require higher doses and longer duration for OCD than for depression.
Candidates generalize anxiety treatment principles (benzodiazepines for acute anxiety) to OCD and PTSD, where they are ineffective and potentially harmful; they also underestimate the required SSRI dose (e.g., fluoxetine 40–60 mg for OCD) and trial duration (10–12 weeks).
What to do instead
Memorize first-line treatments: OCD – SSRIs (higher dose) or clomipramine, plus CBT with exposure and response prevention; PTSD – trauma-focused CBT or EMDR, SSRIs (sertraline, paroxetine) as second-line. Benzodiazepines are not recommended for OCD or PTSD. Create a table of agent, starting dose, target dose, and minimum trial duration for OCD.
In substance use disorders, the candidate recommends detoxification alone without addressing maintenance treatment, or fails to recognize withdrawal syndromes and their timelines (e.g., alcohol withdrawal seizures at 12–48 hours, delirium tremens at 48–96 hours).
Candidates may focus on acute management and forget long-term relapse prevention; they also mix up withdrawal timelines and the drugs used for each (e.g., benzodiazepines for alcohol, buprenorphine for opioids).
What to do instead
For each substance (alcohol, opioids, benzodiazepines, stimulants), learn the withdrawal timeline, first-line withdrawal management, and maintenance options (e.g., naltrexone, acamprosate, disulfiram for alcohol; methadone/buprenorphine for opioids). Practice questions that ask 'what is the next step in management' after detox, and always consider psychosocial interventions alongside pharmacotherapy.
In child and adolescent psychiatry, the candidate applies adult diagnostic criteria without adjusting for developmental stage, or misses red flags such as regression, separation anxiety disorder vs. normal developmental anxiety, and the presentation of depression in children (irritability rather than sadness).
Candidates may not have had enough exposure to child psychiatry and rely on adult templates; they also overlook the importance of collateral information from parents and teachers.
What to do instead
Study developmental norms and age-specific presentations: depression in children often presents as irritability; ADHD requires symptoms before age 12 and in multiple settings; autism spectrum disorder involves social communication deficits and restricted/repetitive behaviors. Always gather collateral information and use validated rating scales (e.g., CBCL, Conners). For treatment, remember that fluoxetine is the only SSRI approved for pediatric depression, and behavioral parent training is first-line for ADHD in young children.
In geriatric psychiatry and neuropsychiatry, the candidate attributes cognitive impairment to depression (pseudodementia) without considering delirium or dementia, or fails to recognize that delirium is a medical emergency and requires immediate workup and management of the underlying cause.
Candidates may overapply the concept of pseudodementia and miss acute delirium; they also may not know the differences in presentation (delirium: acute onset, fluctuating, impaired attention; dementia: insidious, progressive, intact attention until late).
What to do instead
Use the Confusion Assessment Method (CAM) to screen for delirium: acute onset and fluctuating course, inattention, disorganized thinking, altered consciousness. For any acute change in mental status, order a full workup (vitals, glucose, electrolytes, infection screen, medication review) and treat the cause. Differentiate from dementia by history and cognitive testing (e.g., MMSE, MoCA). Remember that depression can cause cognitive symptoms but attention is relatively preserved.
In consultation-liaison and emergency psychiatry, the candidate fails to prioritize medical stabilization and safety (e.g., in a patient with suicidal ideation and a medical condition, they focus only on psychiatric admission without addressing the medical issue), or they miss the legal criteria for involuntary hold and the need for capacity assessment.
Candidates may compartmentalize psychiatric and medical care, forgetting that in C-L psychiatry the interplay is central; they also may not know the local mental health act criteria for detention and the components of capacity (understanding, appreciation, reasoning, expressing a choice).
What to do instead
For emergency questions, follow ABCs (airway, breathing, circulation) first, then assess suicide/homicide risk, then consider medical causes of psychiatric symptoms. For capacity, use the four-ability model and document. For involuntary admission, know the criteria: mental disorder, risk to self or others, and refusal of voluntary treatment. Practice scenarios that require integrating medical and psychiatric management.